The Journal of Organic Chemistry
Page 14 of 24
1
2
3
4
5
6
7
8
(m, 2H), 3.59 – 3.54 (m, 1H), 3.49ꢀ3.46 (m, 2H), 2.43 – 2.40 (m, 1H), 2.20 (d, J = 12.5 Hz,
1H), 1.73ꢀ1.70 (m, 2H), 1.32 (m, 2H), 0.99 – 0.88 (m, 13H); 13C NMR (125 MHz, CDCl3) δ
138.8, 138.5, 138.3, 138.2, 128.3, 128.2, 128.2, 128.0, 127.7, 127.6, 127.6, 127.5, 127.4,
127.4, 100.7, 84.9, 82.1, 77.9, 77.7, 75.5, 74.9, 74.7, 73.6, 69.3, 48.1, 40.9, 34.4, 31.4, 25.2,
23.1, 22.2, 21.0, 15.9.
9
Cholesterol 2,3,4,6ꢀtetraꢀOꢀbenzylꢀβ,αꢀDꢀglucopyranoside, [3k]5c: The compound 3k was
prepared using the glycosylation procedure A. The reaction was carried out between donor 1a
(110 mg, 0.16 mmol) and cholesterol 2k (92 mg, 0.24 mmol) in freshly dried DCM (5 mL) in
the presence of BCF (8 mg, 0.016 mmol) at ꢀ10 oC. Column chromatography purification was
performed using 5% ethyl acetate in hexane which furnished 3k as a white solid (108 mg,
75%); α:β=1:9; TLC Rf = 0.35 (8% ethyl acetate/92% hexane); 1H NMR (500 MHz, CDCl3) δ
7.40ꢀ7.29 (m, 18H), 7.22ꢀ7.21 (m, 2H), 5.38 (d, J = 5.0 Hz, 1H), 4.99 (dd, J = 28.0, 10.9 Hz,
2H), 4.84 (dd, J = 18.0, 10.5 Hz, 2H), 4.76 (d, J = 11.0 Hz, 1H), 4.65ꢀ4.53 (m, 4H), 3.76 (m,
1H), 3.70ꢀ3.59 (m, 4H), 3.50ꢀ3.48 (m, 2H), 2.48 (m, 2H), 2.07ꢀ2.05 (m, 3H), 1.91ꢀ1.89 (m,
2H), 1.61ꢀ1.33 (m, 14H), 1.21ꢀ1.11 (m, 8H), 1.07ꢀ1.05 (m, 4H), 0.96 (d, J = 6.0 Hz, 3H),
0.91 (d, J = 2.0 Hz, 3H), 0.90 (d, J = 2.0 Hz, 3H), 0.73 (s, 3H); 13C NMR (125 MHz, CDCl3)
δ 140.5, 138.6, 138.5, 138.3, 138.1, 128.3, 128.3, 128.2, 128.2, 127.9, 127.8, 127.8, 127.7,
127.6, 127.6, 127.5, 127.5, 121.9, 102.2, 84.8, 82.3, 79.6, 78.0, 75.6, 74.9, 74.9, 74.7, 73.3,
69.1, 56.7, 56.1, 50.1, 42.3, 39.7, 39.5, 39.1, 37.3, 36.7, 36.1, 35.7, 31.9, 31.8, 29.9, 29.6,
28.0, 24.2, 23.8, 22.8, 22.5, 21.0, 19.4, 18.7, 14.1, 11.8.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Ethisteroneꢀ2,3,4,6ꢀtetraꢀOꢀbenzylꢀβ,αꢀDꢀglucopyranoside, [3l]: The compound 3l was
prepared using the glycosylation procedure A. To a solution of donor 1a (90 mg, 0.13 mmol)
and ethisterone 2l (37 mg, 0.12 mmol) in freshly dried DCM (4 mL), BCF (6 mg, 0.013
mmol) was added at ꢀ10 oC. Column chromatography purification was performed using 20%
ethyl acetate in hexane which furnished 3l as white solid (72 mg, 71%); α:β=1.9:1; TLC Rf =
1
0.3 (15% ethyl acetate/85% hexane); H NMR (500 MHz, CDCl3) δ 7.398ꢀ7.28 (m, 18H),
7.18ꢀ7.16 (m, 2H), 5.77 (s, 0.35H), 5.26 (d, J = 3.0 Hz, 0.65H), 5.04ꢀ4.49 (m, 8.65H), 4.08ꢀ
3.98 (m, 1.37H), 3.74ꢀ3.54 (m, 4.55H), 3.35ꢀ3.16 (m, 0.65H), 2.60ꢀ2.04 (m, 5.32H), 1.75ꢀ
1.35 (m, 9H), 1.22 (s, 3H), 1.12ꢀ0.98 (m, 2H), 0.92ꢀ0.90 (m, 5H); 13C NMR (125 MHz,
CDCl3) δ 199.6, 171.1, 139.2, 138.6, 138.4, 138.1, 137.9, 137.8, 137.7, 128.4, 128.3, 128.3,
128.3, 128.1, 128.0, 127.9, 127.9, 127.8, 127.7, 127.6, 127.6, 127.6, 123.8, 114.0, 97.4, 91.2,
87.2, 84.5, 83.1, 81.7, 79.9, 79.6, 77.7, 75.6, 75.6, 74.9, 74.7, 74.1, 73.4, 73.4, 73.2, 70.2,
68.8, 68.5, 53.3, 49.8, 46.6, 38.8, 38.5, 36.1, 35.6, 33.9, 33.7, 32.7, 32.3, 29.6, 29.6, 29.5,
29.4, 29.3, 29.1, 28.9, 23.0, 22.6, 20.6, 17.3, 14.1, 12.6; HRMS (ESIꢀTOF) m/z: [M + H]+
Calcd for C55H63O7 835.4574, found 835.4640.
ACS Paragon Plus Environment